Adela, Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (NCT05366881) | Adela, Inc | 2022-05-03 |
Track Adela, Inc automatically
Every clearance here is in the API, with alerts when new ones post.